Spero Therapeutics (SPRO) Stock Price, Quote, News & History | Benzinga

Spero Therapeutics Inc (SPRO) Stock Price, Quote, News & History

SPRONASDAQ

Trade with Public

Trade with Public

$2.77

-0.14-4.81%

At close: Jun 15, 5:00 PM EST

$2.90

-0.01-0.34%

Pre-Market: 6:38 AM EST

OverviewNews Earnings Events Options Analyst Ratings Insider Trades Short Interest Stock Report

Key Statistics

Open

-

Close

$2.77

Volume / Avg.

13.65K / 601.12K

Day Range

- - -

52 Wk Range

1.80 - 3.22

Market Cap

$167.91M

P/E Ratio

10.26

Dividend Yield

-

Exchange

NASDAQ

RSI

55

Short Interest

3.56%

Days to Cover

1.96

Recent Spero Therapeutics Inc News

Why Is GSK Partner Spero Therapeutics Stock Skyrocketing On Wednesday?

GSK and Spero ended a Phase 3 trial early meeting efficacy goals in cUTIs, positioning its treatment as the first oral carbapenem in the U.S.

Vandana Singh

Why Alphabet Shares Are Trading Higher By Around 6%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Why Limbach Holdings Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Shares of Limbach Holdings, Inc. (NASDAQ: LMB) fell sharply during Thursday’s session after the company reported fourth-quarter financial results and issued FY24 revenue guidance below estimates.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

7.24M

Investing Cash Flow (TTM)

-

Financing Cash Flow (TTM)

-

Free Cash Flow (TTM)

7.24M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

7.24M

Analyst Rating and Forecast

2.0

Sell

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$106.73M

PE Ratio (TTM)

10.26

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

3.01

PB Ratio (TTM)

3.03

Earnings Yield % (TTM)

9.75%

Earnings Yield % (FWD)

-

EV / EBITDA (TTM)

7.53

Price / EBITDA (TTM)

11.63

Price / Free Cash Flow (TTM)

22.76

Book Value / Share

$0.91

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$56.13M

Debt to Equity

0.05

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

-

Close

$2.77

Volume / Avg.

13.65K / 601.12K

Day Range

- - -

52 Wk Range

1.80 - 3.22

Market Cap

$167.91M

P/E Ratio

10.26

Dividend Yield

-

Exchange

NASDAQ

RSI

55

Short Interest

3.56%

Days to Cover

1.96

About

Sector

Health Care

Industry

Biotechnology

Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, developing, and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections and rare diseases. The company's product candidate, teb...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Spero Therapeutics (SPRO) stock?

A

You can purchase shares of Spero Therapeutics (NASDAQ:SPRO) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Spero Therapeutics (SPRO) competitors?

A

There are no as such competitors for Spero Therapeutics.

Q

What is the forecast, or price target, for Spero Therapeutics (SPRO) stock?

A

Spero Therapeutics has a consensus price target of $5.00.

Q

What is the current price for Spero Therapeutics (SPRO)?

A

The stock price for Spero Therapeutics (NASDAQ: SPRO) is $2.9 last updated June 17, 2026 at 6:38 AM EDT.

Q

Does Spero Therapeutics (SPRO) pay a dividend?

A

There are no upcoming dividends for Spero Therapeutics.

Q

When is Spero Therapeutics (NASDAQ:SPRO) reporting earnings?

A

Spero Therapeutics does not have any upcoming earnings scheduled.

Q

Is Spero Therapeutics (SPRO) going to split?

A

There is no upcoming split for Spero Therapeutics.

Q

What sector and industry does Spero Therapeutics (SPRO) operate in?

A

Spero Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.